Showing results (31-40 of 66) with videos related to
Sort By:
Pageof 7
Frontiers in Immunology|December 10, 2024
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case seriesAlice Mariottini, Riccardo Boncompagni, Diletta Cozzi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 28, 2017
Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patientsRaffaele Iorio, Valentina Damato, Amelia Evoli, et al.Annals of Clinical and Translational Neurology|February 6, 2021
Human Leukocyte Antigen Class II associations in late-onset Myasthenia GravisGregorio Spagni, Laura Todi, Gabriele Monte, et al.Journal of Neuroimmunology|October 26, 2013
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosisDomenico Plantone, Alessandro Marti, Giovanni Frisullo, et al.Frontiers in Immunology|April 4, 2025
Prediction, prevention, and precision treatment of immune checkpoint inhibitor neurological toxicity using autoantibodies, cytokines, and microbiotaAlberto Vogrig, Marta Dentoni, Irene Florean, et al.Multiple Sclerosis and Related Disorders|March 8, 2023
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experienceAndrea Bertozzi, Alice Mariottini, Leonardo Marchi, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 21, 2022
Comparison of Fixed and Live Cell-Based Assay for the Detection of AChR and MuSK Antibodies in Myasthenia GravisGregorio Spagni, Matteo Gastaldi, Pietro Businaro, et al.Autoimmunity|April 15, 2015
Poly-autoimmunity in patients with myasthenia gravis: A single-center experienceAmelia Evoli, Pietro Caliandro, Raffaele Iorio, et al.Journal of Neuroimmunology|August 30, 2025
Neuropathic pain in CASPR2 antibody disease spectrum: A systematic reviewSara Cornacchini, Massimiliano Ugo Verza, Mattia Schiavolin, et al.European Journal of Neurology|June 25, 2025
Validation of the "Patient-Acceptable Symptom State" Question as Outcome Measure in AChR Myasthenia Gravis: A Multicentre, Prospective StudyGregorio Spagni, Massimiliano Ugo Verza, Sara Cornacchini, et al.Pageof 7